Correspondence to:

www.cmj.hr Aim To determine the prevalence and types of persistent dyslipidemia in patients treated with different statins to reduce cardiovascular disease (CVD) risk, as well as to de-termine the proportion of high risk patients who did not reach the lipid target values and assess cardiologists ’ fur-ther treatment advice for these patients. Methods This cross-sectional, observational study recruit-ed 1849 outpatients from all parts of Croatia between Jan-uary and September 2011 (44.6 % women), 19 to 90 years old (average age 63.13) treated with statins for at least 6 months. We analyzed how the potency and type of lipid-lowering treatment were correlated with CVD risk level and achieving treatment goals according to 2007 Joint Euro-pean Guidelines on CVD prevention